CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
Amend 004 - Hepatitis A and B Adult and Pediatric - GlaxoSmithKline Inc. | Government contract · CanPursue
Contracts

Amend 004 - Hepatitis A and B Adult and Pediatric - GlaxoSmithKline Inc.

Department of Public Works and Government Services (PSPC)GlaxoSmithKline Inc.E60PH-22HEAB/001/PH
Find on CanadaBuysWatch
Total contract value
$17.3M
Original award value
$162.3K
Start
Mar 3, 2022
End
Mar 31, 2024

Timeline

Official
  • AwardedMar 3, 2022. Original award value: $162.3K
  • Amendment 4Nov 29, 2023. Value change: $17.3M
  • Observed expiryMar 31, 2024
Contract number
E60PH-22HEAB/001/PH
Awarded
Mar 3, 2022
Instrument
—
Status
—
Amendments
1 amendment
Source
CanadaBuys (Find on CanadaBuys)
E60PH-22HEAB/001/PH:4
Related procurement
No linked procurement observed.